目次

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Contract Research Organizations (CROs) Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Demand for Clinical Trials Globally
3.2.1.2 Growing Disease Burden Globally to Fuel CROs Market Growth
3.2.1.3 Rising R&D Investments by Pharmaceutical and Biotech Companies to Boost CROs Market Growth
3.2.1.4 Patent Expiry and Increasing Demand for Generic Drugs Projected to Drive Overall CROs Growth
3.2.2 Market Restraining Factors
3.2.2.1 Intellectual Property Issues May Hamper CROs Industry Growth
3.2.2.2 Shortage of Skilled Labour Post COVID-19 Hampering CRO Industry
3.2.3 Market Opportunities
3.2.3.1 Applications of Artificial Intelligence Could Lead to Faster, Safer and Significantly Less Expensive Clinical Trials
3.2.3.2 Increasing Demand for Biological Therapies to Offer Lucrative Growth Prospects for CROs
3.2.3.3 Growth in Nuclear Medicine Sector
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1.1 Competitive Rivalry: High
3.4.1.2 Threat of New Entrants: Low to Medium
3.4.1.3 Threat of Substitutes: Low to Medium
3.4.1.4 Bargaining Power of Buyers: Medium to High
3.4.1.5 Bargaining Power of Suppliers: Medium to High
3.5 PEST Analysis
3.6 How has the Pharmaceutical Industry Adapted Amidst the Pandemic?
3.7 Why are CROs Adopting Mergers & Acquisitions?
3.8 Mergers & Acquisitions Volume and Public Market Valuations

4 Global Contract Research Organizations (CROs) Market Analysis by Services
4.1 Key Findings
4.2 Services Segment Growth Prospects
4.3 Global Contract Research Organizations (CROs) Market Size Estimation and Forecast by Services
4.4 Preclinical
4.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
4.4.2 Market Share by Region, 2022 & 2032 (%)
4.5 Clinical
4.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
4.5.2 Market Share by Region, 2022 & 2032 (%)
4.6 Laboratory Services
4.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
4.6.2 Market Share by Region, 2022 & 2032 (%)
4.7 Consulting Services
4.7.1 Market Forecast by Region, 2022-2032 (US$ Mn)
4.7.2 Market Share by Region, 2022 & 2032 (%)
4.8 Data Management Services
4.8.1 Market Forecast by Region, 2022-2032 (US$ Mn)
4.8.2 Market Share by Region, 2022 & 2032 (%)

5 Global Contract Research Organizations (CROs) Market Analysis by Company Size
5.1 Key Findings
5.2 Company Size Segment Growth Prospects
5.3 Global Contract Research Organizations (CROs) Market Size Estimation and Forecast by Company Size
5.4 Large Pharma & Biotech Companies
5.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.4.2 Market Share by Region, 2022 & 2032 (%)
5.5 Mid-sized Pharma & Biotech Companies
5.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.5.2 Market Share by Region, 2022 & 2032 (%)
5.6 Small Pharma & Biotech Companies
5.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.6.2 Market Share by Region, 2022 & 2032 (%)

6 Global Contract Research Organizations (CROs) Market Analysis by Drug Type
6.1 Key Findings
6.2 Drug Type Segment Growth Prospects
6.3 Global Contract Research Organizations (CROs) Market Size Estimation and Forecast by Drug Type
6.4 Small Molecules
6.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
6.4.2 Market Share by Region, 2022 & 2032 (%)
6.5 Large Molecules
6.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
6.5.2 Market Share by Region, 2022 & 2032 (%)

7 Global Contract Research Organizations (CROs) Market Analysis by Therapeutic Area
7.1 Key Findings
7.2 Therapeutic Area Segment Growth Prospects
7.3 Global Contract Research Organizations (CROs) Market Size Estimation and Forecast by Therapeutic Area
7.4 Oncology
7.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.4.2 Market Share by Region, 2022 & 2032 (%)
7.5 CNS
7.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.5.2 Market Share by Region, 2022 & 2032 (%)
7.6 Cardiology
7.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.6.2 Market Share by Region, 2022 & 2032 (%)
7.7 Infectious
7.7.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.7.2 Market Share by Region, 2022 & 2032 (%)
7.8 Metabolic
7.8.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.8.2 Market Share by Region, 2022 & 2032 (%)
7.9 Others
7.9.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.9.2 Market Share by Region, 2022 & 2032 (%)

8 Global Contract Research Organizations (CROs) Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
8.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)

9 North America Contract Research Organizations (CROs) Market Analysis
9.1 Key Findings
9.2 North America Contract Research Organizations (CROs) Market Attractiveness Index
9.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
9.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
9.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn)
9.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn)
9.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn)
9.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn)
9.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
9.9 U.S. CROs Market Analysis
9.10 Canada CROs Market Analysis

10 Europe Contract Research Organizations (CROs) Market Analysis
10.1 Key Findings
10.2 Europe Contract Research Organizations (CROs) Market Attractiveness Index
10.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
10.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn)
10.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn)
10.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn)
10.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn)
10.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
10.9 Germany CROs Market Analysis
10.10 UK CROs Market Analysis
10.11 France CROs Market Analysis
10.12 Italy CROs Market Analysis
10.13 Spain CROs Market Analysis
10.14 Rest of Europe CROs Market Analysis

11 Asia Pacific Contract Research Organizations (CROs) Market Analysis
11.1 Key Findings
11.2 Asia Pacific Contract Research Organizations (CROs) Market Attractiveness Index
11.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
11.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn)
11.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn)
11.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn)
11.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn)
11.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
11.9 Japan CROs Market Analysis
11.10 China CROs Market Analysis
11.11 India CROs Market Analysis
11.12 Australia CROs Market Analysis
11.13 South Korea CROs Market Analysis
11.14 Rest of Asia Pacific CROs Market Analysis

12 Latin America Contract Research Organizations (CROs) Market Analysis
12.1 Key Findings
12.2 Latin America Contract Research Organizations (CROs) Market Attractiveness Index
12.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
12.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
12.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn)
12.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn)
12.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn)
12.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn)
12.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
12.9 Brazil CROs Market Analysis
12.10 Mexico CROs Market Analysis
12.11 Rest of Latin America

13 MEA Contract Research Organizations (CROs) Market Analysis
13.1 Key Findings
13.2 MEA Contract Research Organizations (CROs) Market Attractiveness Index
13.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
13.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
13.5 Market Size Estimation and Forecast by Services, 2022-2032 (US$ Mn)
13.5.1 Market Forecast by Clinical Phase, 2022-2032 (US$ Mn)
13.6 Market Size Estimation and Forecast by Company Size, 2022-2032 (US$ Mn)
13.7 Market Size Estimation and Forecast by Drug Type, 2022-2032 (US$ Mn)
13.8 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
13.9 GCC CROs Market Analysis
13.10 South Africa CROs Market Analysis
13.11 Rest of MEA CROs Market Analysis

14 Company Profiles
14.1 Competitive Landscape, 2021
14.2 Charles River Laboratories
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2016-2021
14.2.3.2 Regional Market Shares, 2021
14.2.3.3 Gross Profit, 2016-2021
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 Clinipace
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Product Benchmarking
14.4 CMIC HOLDING Co., LTD.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2016-2021
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 EPS Corporation
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2016-2021
14.5.4 Product Benchmarking
14.6 ICON plc
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2016-2021
14.6.3.2 Gross Profit, 2016-2021
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 IQVIA HOLDINGS INC.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2016-2021
14.7.3.2 Regional Market Shares, 2021
14.7.3.3 Gross Profit, 2016-2021
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Labcorp Drug Development
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2016-2021
14.8.3.2 Regional Market Shares, 2021
14.8.3.3 Gross Profit, 2016-2021
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 MedPace
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2016-2021
14.9.3.2 Gross Profit, 2016-2021
14.9.4 Product Benchmarking
14.10 Parexel
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.10.4 Strategic Outlook
14.11 PPD (ThermoFisher Scientific Inc.)
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2016-2021
14.11.3.2 Regional Market Shares, 2021
14.11.3.3 Gross Profit, 2016-2021
14.11.3.4 R&D, 2016-2021
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 Syneos Health
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2016-2021
14.12.3.2 Regional Market Shares, 2021
14.12.3.3 Gross Profit, 2016-2021
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 Worldwide Clinical Trials
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.13.4 Strategic Outlook
14.14 Wuxi AppTec
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2016-2021
14.14.3.2 Regional Market Shares, 2021
14.14.3.3 Gross Profit, 2016-2020
14.14.4 Product Benchmarking
14.14.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

List of Tables
Table 1 Global Contract Research Organizations (CROs) Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Global Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 7 Preclinical Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 8 Preclinical Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 9 Laboratory Services Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 10 Consulting Services Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 11 Data Management Services Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 12 Global Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 13 Large Pharma & Biotech Companies Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 14 Mid-sized Pharma & Biotech Companies Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 15 Small Pharma & Biotech Companies Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 16 Global Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 17 Small Molecules Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 18 Large Molecules Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 19 Global Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 20 Oncology Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 21 CNS Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 22 Cardiology Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 23 Infectious Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 24 Metabolic Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 25 Others Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 26 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 27 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 28 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 29 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 30 Global Contract Research Organizations (CRO) Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 31 North America Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 32 North America Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 33 North America Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 34 North America Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 35 North America Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 36 North America Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 37 U.S. Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 38 Canada Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 39 Europe Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 40 Europe Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 41 Europe Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 42 Europe Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 43 Europe Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 44 Europe Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 45 Germany Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 46 UK Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 47 France Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 48 Italy Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 49 Spain Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 50 Rest of Europe Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 51 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 52 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 53 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 54 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 55 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 56 Asia Pacific Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 57 Japan Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 58 China Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 59 India Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 60 Australia Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 61 South Korea Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 62 Rest of Asia Pacific Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 63 Latin America Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 64 Latin America Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 65 Latin America Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 66 Latin America Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 67 Latin America Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 68 Latin America Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 69 Brazil Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 70 Mexico Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 71 Rest of Latin America Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 72 MEA Contract Research Organizations (CRO) Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 73 MEA Contract Research Organizations (CRO) Market Forecast by Service, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 74 MEA Contract Research Organizations (CRO) Market Forecast by Clinical Phase, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 75 MEA Contract Research Organizations (CRO) Market Forecast by Company Size, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 76 MEA Contract Research Organizations (CRO) Market Forecast by Drug Type, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 77 MEA Contract Research Organizations (CRO) Market Forecast by Therapeutic Area, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 78 GCC Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 79 South Africa Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 80 Rest of MEA Contract Research Organizations (CRO) Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 81 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Charles River Laboratories: Product Benchmarking
Table 83 Charles River Laboratories: Strategic Outlook
Table 84 Clinipace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Clinipace: Product Benchmarking
Table 86 CMIC HOLDING Co., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 CMIC HOLDING Co., LTD.: Product Benchmarking
Table 88 CMIC HOLDING Co., LTD.: Strategic Outlook
Table 89 EPS Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 EPS Corporation: Product Benchmarking
Table 91 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 ICON plc: Product Benchmarking
Table 93 ICON plc: Strategic Outlook
Table 94 IQVIA HOLDINGS INC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 IQVIA HOLDINGS INC.: Product Benchmarking
Table 96 IQVIA HOLDINGS INC.: Strategic Outlook
Table 97 Labcorp Drug Development: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Labcorp Drug Development: Product Benchmarking
Table 99 Labcorp Drug Development: Strategic Outlook
Table 100 MedPace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 MedPace: Product Benchmarking
Table 102 Parexel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Parexel: Product Benchmarking
Table 104 Parexel: Strategic Outlook
Table 105 PPD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 PPD: Product Benchmarking
Table 107 PPD: Strategic Outlook
Table 108 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Syneos Health: Product Benchmarking
Table 110 Syneos Health: Strategic Outlook
Table 111 Worldwide Clinical Trials: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Worldwide Clinical Trials: Product Benchmarking
Table 113 Worldwide Clinical Trials: Strategic Outlook
Table 114 Wuxi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Wuxi AppTec: Product Benchmarking
Table 116 Wuxi AppTec: Strategic Outlook
?

List of Figures
Figure 1 Global Contract Research Organizations (CROs) Market Segmentation
Figure 2 Global Contract Research Organizations (CROs) Market by Services: Market Attractiveness Index
Figure 3 Global Contract Research Organizations (CROs) Market by Company Size: Market Attractiveness Index
Figure 4 Global Contract Research Organizations (CROs) Market by Drug Type: Market Attractiveness Index
Figure 5 Global Contract Research Organizations (CROs) Market by Therapeutic Area: Market Attractiveness Index
Figure 6 Global Contract Research Organizations (CROs) Market Attractiveness Index by Region
Figure 7 Global Contract Research Organizations (CROs) Market: Market Dynamics
Figure 8 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 9 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 10 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 11 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 12 Porter’s Five Forces Analysis
Figure 13 PEST Analysis
Figure 14 Deal Volume, 2017-2021
Figure 15 Global Contract Research Organizations (CROs) Market Attractiveness Index by Services
Figure 16 Global Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million)
Figure 17 Global Contract Research Organizations (CROs) Market Share Forecast by Services, 2022, 2027, 2032 (%)
Figure 18 Preclinical Market Forecast by Region, 2022-2032 (US$ million)
Figure 19 Preclinical Market Share Forecast by Region, 2022 & 2032 (%)
Figure 20 Clinical Market Forecast by Region, 2022-2032 (US$ million)
Figure 21 Clinical Market Share Forecast by Region, 2022 & 2032 (%)
Figure 22 Laboratory Services Market Forecast by Region, 2022-2032 (US$ million)
Figure 23 Laboratory Services Market Share Forecast by Region, 2022 & 2032 (%)
Figure 24 Consulting Services Market Forecast by Region, 2022-2032 (US$ million)
Figure 25 Consulting Services Market Share Forecast by Region, 2022 & 2032 (%)
Figure 26 Data Management Services Market Forecast by Region, 2022-2032 (US$ million)
Figure 27 Data Management Services Market Share Forecast by Region, 2022 & 2032 (%)
Figure 28 Global Contract Research Organizations (CROs) Market Attractiveness Index by Company Size
Figure 29 Global Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million)
Figure 30 Global Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022, 2027, 2032 (%)
Figure 31 Large Pharma & Biotech Companies Market Forecast by Region, 2022-2032 (US$ million)
Figure 32 Large Pharma & Biotech Companies Market Share Forecast by Region, 2022 & 2032 (%)
Figure 33 Mid-sized Pharma & Biotech Companies Market Forecast by Region, 2022-2032 (US$ million)
Figure 34 Mid-sized Pharma & Biotech Companies Market Share Forecast by Region, 2022 & 2032 (%)
Figure 35 Small Pharma & Biotech Companies Market Forecast by Region, 2022-2032 (US$ million)
Figure 36 Small Pharma & Biotech Companies Market Share Forecast by Region, 2022 & 2032 (%)
Figure 37 Global Contract Research Organizations (CROs) Market Attractiveness Index by Drug Type
Figure 38 Global Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million)
Figure 39 Global Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022, 2027, 2032 (%)
Figure 40 Small Molecules Market Forecast by Region, 2022-2032 (US$ million)
Figure 41 Small Molecules Market Share Forecast by Region, 2022 & 2032 (%)
Figure 42 Large Molecules Market Forecast by Region, 2022-2032 (US$ million)
Figure 43 Large Molecules Market Share Forecast by Region, 2022 & 2032 (%)
Figure 44 Global Contract Research Organizations (CROs) Market Attractiveness Index by Therapeutic Area
Figure 45 Global Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 46 Global Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022, 2027, 2032 (%)
Figure 47 Oncology Market Forecast by Region, 2022-2032 (US$ million)
Figure 48 Oncology Market Share Forecast by Region, 2022 & 2032 (%)
Figure 49 CNS Market Forecast by Region, 2022-2032 (US$ million)
Figure 50 CNS Market Share Forecast by Region, 2022 & 2032 (%)
Figure 51 Cardiology Market Forecast by Region, 2022-2032 (US$ million)
Figure 52 Cardiology Market Share Forecast by Region, 2022 & 2032 (%)
Figure 53 Infectious Market Forecast by Region, 2022-2032 (US$ million)
Figure 54 Infectious Market Share Forecast by Region, 2022 & 2032 (%)
Figure 55 Metabolic Market Forecast by Region, 2022-2032 (US$ million)
Figure 56 Metabolic Market Share Forecast by Region, 2022 & 2032 (%)
Figure 57 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 58 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 59 Global Contract Research Organizations (CROs) Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR %)
Figure 60 Global Contract Research Organizations (CROs) Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 61 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Figure 62 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 63 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 64 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 65 Global Contract Research Organizations (CROs) Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 66 North America Contract Research Organizations (CROs) Market Attractiveness Index
Figure 67 North America Contract Research Organizations (CROs) Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 68 North America Contract Research Organizations (CROs) Market Forecast by Country, 2022-2032 (US$ million)
Figure 69 North America Contract Research Organizations (CROs) Market Share Forecast by Country, 2022 & 2032 (%)
Figure 70 North America Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million)
Figure 71 North America Contract Research Organizations (CROs) Market Share Forecast by Services, 2022 & 2032 (%)
Figure 72 North America Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million)
Figure 73 North America Contract Research Organizations (CROs) Market Share Forecast by Clinical Phase, 2022 & 2032 (%)
Figure 74 North America Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million)
Figure 75 North America Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022 & 2032 (%)
Figure 76 North America Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million)
Figure 77 North America Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022 & 2032 (%)
Figure 78 North America Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 79 North America Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 80 U.S. Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 81 Canada Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 82 Europe Contract Research Organizations (CROs) Market Attractiveness Index
Figure 83 Europe Contract Research Organizations (CROs) Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 84 Europe Contract Research Organizations (CROs) Market Forecast by Country, 2022-2032 (US$ million)
Figure 85 Europe Contract Research Organizations (CROs) Market Share Forecast by Country, 2022 & 2032 (%)
Figure 86 Europe Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million)
Figure 87 Europe Contract Research Organizations (CROs) Market Share Forecast by Services, 2022 & 2032 (%)
Figure 88 Europe Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million)
Figure 89 Europe Contract Research Organizations (CROs) Market Share Forecast by Clinical Phase, 2022 & 2032 (%)
Figure 90 Europe Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million)
Figure 91 Europe Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022 & 2032 (%)
Figure 92 Europe Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million)
Figure 93 Europe Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022 & 2032 (%)
Figure 94 Europe Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 95 Europe Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 96 Germany Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 97 UK Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 98 France Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 99 Italy Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 100 Spain Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 101 Rest of Europe Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 102 Asia Pacific Contract Research Organizations (CROs) Market Attractiveness Index
Figure 103 Asia Pacific Contract Research Organizations (CROs) Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 104 Asia Pacific Contract Research Organizations (CROs) Market Forecast by Country, 2022-2032 (US$ million)
Figure 105 Asia Pacific Contract Research Organizations (CROs) Market Share Forecast by Country, 2022 & 2032 (%)
Figure 106 Asia Pacific Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million)
Figure 107 Asia Pacific Contract Research Organizations (CROs) Market Share Forecast by Services, 2022 & 2032 (%)
Figure 108 Asia Pacific Contract Research Organizations (CROs) Market Forecast by Clinical Phase, 2022-2032 (US$ million)
Figure 109 Asia Pacific Contract Research Organizations (CROs) Market Share Forecast by Clinical Phase, 2022 & 2032 (%)
Figure 110 Asia Pacific Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million)
Figure 111 Asia Pacific Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022 & 2032 (%)
Figure 112 Asia Pacific Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million)
Figure 113 Asia Pacific Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022 & 2032 (%)
Figure 114 Asia Pacific Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 115 Asia Pacific Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 116 Japan Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 117 China Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 118 India Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 119 Australia Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 120 South Korea Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 121 Rest of Asia Pacific Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 122 Latin America Contract Research Organizations (CROs) Market Attractiveness Index
Figure 123 Latin America Contract Research Organizations (CROs) Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 124 Latin America Contract Research Organizations (CROs) Market Forecast by Country, 2022-2032 (US$ million)
Figure 125 Latin America Contract Research Organizations (CROs) Market Share Forecast by Country, 2022 & 2032 (%)
Figure 126 Latin America Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million)
Figure 127 Latin America Contract Research Organizations (CROs) Market Share Forecast by Services, 2022 & 2032 (%)
Figure 128 Latin America Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million)
Figure 129 Latin America Contract Research Organizations (CROs) Market Share Forecast by Clinical Phase, 2022 & 2032 (%)
Figure 130 Latin America Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million)
Figure 131 Latin America Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022 & 2032 (%)
Figure 132 Latin America Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million)
Figure 133 Latin America Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022 & 2032 (%)
Figure 134 Latin America Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 135 Latin America Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 136 Brazil Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 137 Mexico Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 138 Rest of Latin America Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 139 MEA Contract Research Organizations (CROs) Market Attractiveness Index
Figure 140 MEA Contract Research Organizations (CROs) Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 141 MEA Contract Research Organizations (CROs) Market Forecast by Country, 2022-2032 (US$ million)
Figure 142 MEA Contract Research Organizations (CROs) Market Share Forecast by Country, 2022 & 2032 (%)
Figure 143 MEA Contract Research Organizations (CROs) Market Forecast by Services, 2022-2032 (US$ million)
Figure 144 MEA Contract Research Organizations (CROs) Market Share Forecast by Services, 2022 & 2032 (%)
Figure 145 MEA Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million)
Figure 146 MEA Contract Research Organizations (CROs) Market Share Forecast by Clinical Phase, 2022 & 2032 (%)
Figure 147 MEA Contract Research Organizations (CROs) Market Forecast by Company Size, 2022-2032 (US$ million)
Figure 148 MEA Contract Research Organizations (CROs) Market Share Forecast by Company Size, 2022 & 2032 (%)
Figure 149 MEA Contract Research Organizations (CROs) Market Forecast by Drug Type, 2022-2032 (US$ million)
Figure 150 MEA Contract Research Organizations (CROs) Market Share Forecast by Drug Type, 2022 & 2032 (%)
Figure 151 MEA Contract Research Organizations (CROs) Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 152 MEA Contract Research Organizations (CROs) Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 153 GCC Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 154 South Africa Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 155 Rest of MEA Contract Research Organizations (CROs) Market Forecast, 2022-2032 (US$ million)
Figure 156 Global Contract Research Organizations (CROs) Market: Company Share/Ranking, 2021
Figure 157 Charles River Laboratories: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 158 Charles River Laboratories: Regional Market Shares (%), 2021
Figure 159 Charles River Laboratories: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 160 CMIC HOLDING Co., LTD.: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 161 EPS Corporation: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 162 ICON plc: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 163 ICON plc: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 164 IQVIA HOLDINGS INC.: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 165 IQVIA HOLDINGS INC.: Regional Market Shares (%), 2021
Figure 166 IQVIA HOLDINGS INC.: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 167 Labcorp Drug Development: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 168 Labcorp Drug Development: Regional Market Shares (%), 2021
Figure 169 Labcorp Drug Development: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 170 MedPace: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 171 MedPace: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 172 PPD: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 173 PPD: Regional Market Shares (%), 2021
Figure 174 PPD: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 175 PPD: R&D, 2016-2021 (US$ million, AGR %)
Figure 176 Syneos Health: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 177 Syneos Health: Regional Market Shares (%), 2021
Figure 178 Syneos Health: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 179 Wuxi AppTec: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 180 Wuxi AppTec: Regional Market Shares (%), 2021
Figure 181 Wuxi AppTec: Gross Profit, 2016-2020 (US$ million, AGR %)